Alexandra Delaubert

Alexandra Delaubert is an experienced specialist in USP process development with a career spanning over two decades in the biopharmaceutical industry. Currently serving as a Specialist/Senior Technician at Fresenius Kabi since March 2021, Alexandra focuses on the design, planning, and execution of experiments for biosimilars monoclonal antibodies, along with acting as the technical lead for 3L bioreactors. Previous roles include Senior Cell Culture Technician at Merck Group, where expertise in various bioreactor setups was developed, and a foundation in virology and cell culture as a Technician at Pierre Fabre. Alexandra holds multiple degrees in the life sciences, including a Master of Immunotechnology from Université d'Aix-Marseille II, a Maîtrise de Sciences et Techniques BioIndustrielles from Université d'Orléans, and a DUT de Biologie Appliquée from Université de Tours.